4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001562180-18-001042
Director sold 1,000 shares at $14.62 ($14,620)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nash Duane Director | 2018-02-15 | Sale | −1,000 | $14.62 | $14,620 | 21,499 | D: show line 1 in the form |
| Open-market sales · 1,000 sh · avg $14.62 · $14,620 | |||||||
Loading xslF345X03/primarydocument.xml…